tiprankstipranks
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market

Mineralys Therapeutics, Inc. (MLYS) Ownership - Who Owns Mineralys Therapeutics, Inc.?

Compare
590 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 21, 2025
xxxxxxxxxxxxx
$43350000
Nov 13, 2025
xxxxxxxxxxxxx
$689687
Nov 13, 2025
xxxxxxxxxxxxx
$5363192
Nov 13, 2025
xxxxxxxxxxxxx
$9087664

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,910,038Insider9.60%207,163,895
7,329,950Insider8.90%191,971,391
7,323,750Institution8.89%191,809,013
5,877,218Insider7.13%153,924,339
5,674,916Insider6.89%148,626,050
2,695,165Institution3.27%70,586,371
2,353,845Institution2.86%61,647,201
2,276,697Institution2.76%59,626,694
2,162,925Institution2.62%56,647,006
1,542,600Institution1.87%40,400,694

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,162,925Institution2.62%56,647,006
1,542,600Institution1.87%40,400,694
1,163,290Institution1.41%30,466,565
940,669Institution1.14%24,636,121
713,061Institution0.87%18,675,068
645,332Institution0.78%16,901,245
553,700Institution0.67%14,501,403
542,701Institution0.66%14,213,339
528,200Institution0.64%13,833,558
434,160Institution0.53%11,370,650

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,174,907Institution2.64%58,700,740
1,616,465Institution1.96%49,932,604
1,108,397Institution1.35%29,028,917
598,243Institution0.73%18,479,726
408,366Institution0.50%10,695,106
393,777Institution0.48%10,313,020
270,139Institution0.33%7,291,052
222,732Institution0.27%6,880,191
137,534Institution0.17%4,248,425
123,890Institution0.15%3,244,679

FAQ

Who Owns Mineralys Therapeutics, Inc. (MLYS)?
Currently, no data Available
What percentage of Mineralys Therapeutics, Inc. (MLYS) stock is held by institutional investors?
Currently, no data Available
What percentage of Mineralys Therapeutics, Inc. (MLYS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Mineralys Therapeutics, Inc. (MLYS)?
Brian Taylor Slingsby owns the most shares of Mineralys Therapeutics, Inc. (MLYS).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.